Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for pain in children with severe neurological impairment
NCT04619862Phase 2Recruiting
- Sponsor
- University of British Columbia
- Start
- May 2021
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gabapentin in pain, irritability, neuropathic pain, sponsored by University of British Columbia. Started May 2021; status: recruiting.
02
Drugs
gabapentin
03
Conditions
painirritabilityneuropathic pain
Beyond the preview
Go deeper on NCT04619862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04619862.